Dr. Timothy Chase, a urogynecologist with Novant Health Glen Meade OB/GYN talks with Jessica Keisling about bladder issues.
Catheter Precision, Inc. (NYSE American:VTAK), currently valued at $3.55 million in market capitalization, recently held a ...
Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...
Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval for TAR-200, its investigational ...
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...
Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.
The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...
UB researcher Chelsie Armbruster is looking at how the urinary tract defends against infection and how understudied pathogens ...
CG Oncology's stock has dropped 40% since its IPO peak, driven by profit-taking and competitive concerns despite promising ...
The family of a woman who died after complications from surgery have filed a lawsuit against the Medical University of South Carolina and one of their doctors claiming their medical malpractice and ...
Introduction The Walrus balloon guide catheter (BGC) is a new generation of BGC, designed to eliminate conventional limitations during mechanical thrombectomy. Objective To report a ...
Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the ...